QUANTA AND SC+

Quanta Announces Formation of North American Medical Advisory Board

Retrieved on: 
Wednesday, September 1, 2021
Biotechnology, Other Health, Health, Pharmaceutical, Clinical Trials, San Diego Magazine, Toronto General Hospital, Peritoneal dialysis, Leadership, Biomarker, Natera, Royal college, Research, CMO, Health, Clinical Journal of the American Society of Nephrology, United Kingdom, Hypertension, Internal medicine, Medicine, University, Population health, National Kidney Foundation, ICU, Royal College of Physicians and Surgeons of Canada, Associate, CEO, Kidney disease, Genetic testing, Hospital, Freedom, American Society of Nephrology, University Health Network, Dialysis, Waste, SC, Cincinnati, United, University Hospitals Ahuja Medical Center, Chronic kidney disease, University of Pittsburgh Medical Center, MAB, Food and Drug Administration, FDA, Prescription, Physician, Society, Economics, Kidney, Kidney failure, Patient, Renal replacement therapy, FRCPC, Medical device, Pharmaceutical industry, Hemodialysis, Quanta and SC+, HEMODIALYSIS, QUANTA AND SC+

Quanta Dialysis Technologies Ltd (Quanta or the Company), a medical technology leader delivering on its vision to give control to dialysis users through more flexible and accessible dialysis care, announced today the formation of a North American Medical Advisory Board (MAB).

Key Points: 
  • Quanta Dialysis Technologies Ltd (Quanta or the Company), a medical technology leader delivering on its vision to give control to dialysis users through more flexible and accessible dialysis care, announced today the formation of a North American Medical Advisory Board (MAB).
  • The Medical Advisory Board consists of prominent nephrologists and is chaired by Dr. Paul Komenda, chief medical officer (CMO) at Quanta.
  • I am thrilled to welcome this diverse group of nephrologists who are performing at the top of their field to our North American Medical Advisory Board, said Dr. Komenda.
  • Members of Quantas North American Medical Advisory Board include:
    Dr. Christos Argyropoulos, MD: Dr. Christos Argyropoulos is the division chief of nephrology at the University of New Mexico Health Sciences Center.